Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis

Journal of Neurology

Volumn 259, Issue 5, 2012, Pages 855-861

  D'hooghe, M B ^a   Haentjens, P ^b   Nagels, G ^a,c   D'Hooghe, T ^a,d   De Keyser, J ^a,b,e  

^a National MS Center Melsbroek   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF MONS   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Female; Menarche; Multiple sclerosis; Oral contraceptives; Pregnancy

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BELGIUM; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MULTIPARA; MULTIPLE SCLEROSIS; NULLIPARA; ORAL CONTRACEPTION; PHYSICAL DISABILITY; PREGNANCY; PRIORITY JOURNAL; RISK REDUCTION;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MENARCHE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PREGNANCY; PREGNANCY COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; YOUNG ADULT;

EID: 84862558190     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6267-7     Document Type: Article

References (29)

1. Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: A systematic review. Neurology 71(2):129-135. doi:10.1212/01.wnl. 0000316802.35974.34
2. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (2006) Sex ratio of multiple sclerosis in Canada: A longitudinal study. Lancet Neurol 5(11):932-936. doi: 10.1016/S1474-4422(06)70581-6 (Pubitemid 44556546)
3. Ramagopalan SV, Valdar W, Criscuoli M, DeLuca GC, Dyment DA, Orton SM, Yee IM, Ebers GC, Sadovnick AD (2009) Age of puberty and the risk of multiple sclerosis: A population based study. Eur J Neurol 16(3):342-347. doi:10.1111/j.1468-1331. 2008.02431.x
4. Sloka JS, Pryse-Phillips WE, Stefanelli M (2006) The relation between menarche and the age of first symptoms in a multiple sclerosis cohort. Mult Scler 12(3):333-339 (Pubitemid 43827190)
5. Holmqvist P, Wallberg M, Hammar M, Landtblom AM, Brynhildsen J (2006) Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54(2):149-153. doi: 10.1016/j.maturitas.2005.10.003 (Pubitemid 44294287)
6. Poser S, Raun NE, Wikstrom J, Poser W (1979) Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 59(2-3):108-118 (Pubitemid 9175655)
7. Holmqvist P, Hammar M, Landtblom AM, Brynhildsen J (2010) Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril 10.1016/j.fertnstert.2010.06.045
8. Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med 339(5):285-291. doi:10.1056/ NEJM199807303390501 (Pubitemid 28366416)
9. Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR (2002) Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52(4):421-428. doi: 10.1002/ana.10301
10. Runmarker B, Andersen O (1995) Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118(Pt 1):253-261
11. D'Hooghe MB, Nagels G, Uitdehaag BM (2010) Long-term effects of childbirth in MS. J Neurol Neurosurg Psychiatry 81(1):38-41. doi:10.1136/jnnp.2008.163816
12. Koch M, Uyttenboogaart M, Heersema D, Steen C, De Keyser J (2009) Parity and secondary progression in multiple sclerosis. J Neurol Neurosurg Psychiatry 80(6):676-678. doi:10.1136/ jnnp.2008.160911
13. Lisak RP (2007) Neurodegeneration in multiple sclerosis: Defining the problem. Neurology 68(22 Suppl 3):S5-12. doi: 10.1212/01.wnl.0000275227.74893. bd. (discussion S43-54)
14. Wilkins A, Scolding N (2008) Protecting axons in multiple sclerosis. Mult Scler 14(8):1013-1025. doi:10.1177/135245 8508091370
15. Thompson AJ, Kermode AG, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, McDonald WI (1990) Patterns of disease activity in multiple sclerosis: Clinical and magnetic resonance imaging study. BMJ 300(6725):631-634 (Pubitemid 20107324)
16. van Ooteghem P, D'Hooghe MB, Vlietinck R, Carton H (1994) Prevalence of multiple sclerosis in Flanders, Belgium. Neuroepidemiology 13(5):220-225 (Pubitemid 24229137)
17. Kobelt G (2006) Costs and quality of life for patients with multiple sclerosis in Belgium. Eur J Health Econ 7(Suppl 2):S24-S33. doi:10.1007/s10198- 006-0377-7
18. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 33(11):1444-1452 (Pubitemid 14237132)
19. Hohol MJ, Orav EJ, Weiner HL (1999) Disease steps in multiple sclerosis: A longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 5(5):349-354 (Pubitemid 29505050)
20. Roullet E, Verdier-Taillefer MH, Amarenco P, Gharbi G, Alperovitch A, Marteau R (1993) Pregnancy and multiple sclerosis: A longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 56(10):1062-1065 (Pubitemid 23304696)
21. Gregg C, Shikar V, Larsen P, Mak G, Chojnacki A, Yong VW, Weiss S (2007) White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci 27(8):1812-1823. doi: 10.1523/JNEUROSCI.4441-06.2007
22. Blakemore SJ, Burnett S, Dahl RE (2010) The role of puberty in the developing adolescent brain. Hum Brain Mapp 31(6):926-933. doi:10.1002/hbm.21052
23. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL (1999) Brain development during childhood and adolescence: A longitudinal MRI study. Nat Neurosci 2(10):861-863. doi:10.1038/13158 (Pubitemid 30602596)
24. Kupershmidt L, Amit T, Bar-Am O, Youdim MB, Blumenfeld Z (2007) The neuroprotective effect of activin A and B: Implication for neurodegenerative diseases. J Neurochem 103(3):962-971. doi:10.1111/j.1471-4159.2007.04785.x (Pubitemid 47568714)
25. Bentzen J, Flachs EM, Stenager E, Bronnum-Hansen H, Koch-Henriksen N (2010) Prevalence of multiple sclerosis in Denmark 1950-2005. Mult Scler 16(5):520-525. doi:10.1177/1352458510364197
26. Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T (2007) Validation of the NARCOMS registry: Diagnosis. Mult Scler 13(6):770-775. doi:10.1177/ 1352458506075031 (Pubitemid 47074101)
27. Bowen J, Gibbons L, Gianas A, Kraft GH (2001) Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test. Mult Scler 7(3):201-206 (Pubitemid 32651821)
28. Ingram G, Colley E, Ben-Shlomo Y, Cossburn M, Hirst CL, Pickersgill TP, Robertson NP (2010) Validity of patient-derived disability and clinical data in multiple sclerosis. Mult Scler 16(4):472-479. doi:10.1177/1352458509358902
29. Must A, Phillips SM, Naumova EN, Blum M, Harris S, Dawson-Hughes B, Rand WM (2002) Recall of early menstrual history and menarcheal body size: After 30 years, how well do women remember? Am J Epidemiol 155(7):672-679 (Pubitemid 34246100)